We don't know whether the most recent response to this request contains information or not – if you are BEN HOLDSWORTH please sign in and let everyone know.

Treatment for Lung Cancer

We're waiting for BEN HOLDSWORTH to read recent responses and update the status.

Dear University Hospitals Coventry and Warwickshire NHS Trust,

The following question is being requested on behalf of Novartis. The purpose of these questions is to understand the variability of treatment within your trust and in context to
the rest of the country.

Q1. In the past 3 months (or the latest 3 months data you have available), how many metastatic non-small cell lung cancer (NSCLC) patients were treated with any of the following:
• Afatinib
• Alectinib
• Atezolizumab monotherapy
• Atezolizumab in combination
• Bevacizumab
• Brigatinib
• Capmatenib
• Ceritinib
• Crizotinib
• Dacomitinib
• Dabrafenib with Trametinib
• Docetaxel monotherapy
• Durvalumab
• Erlotinib
• Gefitinib
• Gemcitabine
• Nintedanib with Docetaxel
• Nivolumab
• Osimertinib
• Paclitaxel
• Pembrolizumab monotherapy
• Pembrolizumab in combination
• Pemetrexed with Carboplatin/Cisplatin
• Tepotinib
• Vinorelbine with Cisplatin/Carboplatin
• Any other SACT
• Palliative care only

Thank you for taking the time to answer this question and I look forward to hearing from you.

Yours faithfully,

Ben Holdsworth

uhcw@infreemation.co.uk, University Hospitals Coventry and Warwickshire NHS Trust

 
University Hospital
Clifford Bridge Road
Walsgrave
Coventry
CV2 2DX

Direct Line: 024 76968771
www.uhcw.nhs.uk

 

Dear Requester

We acknowledge receipt of your email to UHCW:

Freedom of Information Request Form

If you have submitted a request under the Freedom of Information Act
(FOIA) your request will be considered and you will receive our response
within the statutory timescale of 20 working days.

The reference number for your email is FOI/2051.

Should you have any further inquiries concerning this matter, please reply
to this email leaving the subject line unchanged.

Yours sincerely,
UHCW

uhcw@infreemation.co.uk, University Hospitals Coventry and Warwickshire NHS Trust

 
University Hospital
Clifford Bridge Road
Walsgrave
Coventry
CV2 2DX

Direct Line: 024 76968771
www.uhcw.nhs.uk

 

Our Ref: FOI/2051
Date: 3 October 2022

By email only

 

Dear Requester

We write further to your request for information under the Freedom of
Information Act received 26th August 2022.  We have set out your request,
together with our response below. 

Q1. In the past 3 months (or the latest 3 months data you have available),
how many metastatic non-small cell lung cancer (NSCLC) patients were
treated with any of the following:
* Afatinib 1-10
* Alectinib 1-10
* Atezolizumab monotherapy 1-10
* Atezolizumab in combination 0
* Bevacizumab 0
* Brigatinib 1-10
* Capmatenib 0
* Ceritinib 0
* Crizotinib 0
* Dacomitinib 1-10
* Dabrafenib with Trametinib 0
* Docetaxel monotherapy 0
* Durvalumab 1-10
* Erlotinib 0
* Gefitinib 1-10
* Gemcitabine 0
* Nintedanib with Docetaxel 0
* Nivolumab 0
* Osimertinib 1-10
* Paclitaxel 1-10
* Pembrolizumab monotherapy 12
* Pembrolizumab in combination 1-10
* Pemetrexed with Carboplatin/Cisplatin 1-10
* Tepotinib 0
* Vinorelbine with Cisplatin/Carboplatin 1-10
* Any other SACT 1-10
* Palliative care only 0 patients between 01 July 2022 – 30 September 2022

Please note that due to the availability of inferred or derived
information from other sources, there may be a risk of identification
owing to the very low numbers involved. For this reason, we are only able
to provide you with aggregated answers.

As we have provided the information that we do hold your request is now
closed.  We trust that this is satisfactory but if you are dissatisfied
with the way that it has been handled you have the right to ask for an
internal review.  Internal review requests should be submitted within two
months of the date of receipt of the response to your original letter and
should be addressed to: David Walsh, Director of Corporate Affairs,
University Hospitals Coventry & Warwickshire NHS Trust, Clifford Bridge
Road, Coventry CV2 2DX.

If you are not content with the outcome of the internal review, you have
the right to apply directly to the Information Commissioner for a
decision.  The Information Commissioner can be contacted at: Information
Commissioner’s Office, Wycliffe House, Water Lane, Wilmslow, Cheshire, SK9
5AF.

Yours sincerely

 

 

 

Andrea Phillips
FOI & Access to Health Records Manager

 

We don't know whether the most recent response to this request contains information or not – if you are BEN HOLDSWORTH please sign in and let everyone know.